Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0041-1345(97)00186-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Push toward pre-emptive kidney transplantation - for sure?
Clin Kidney J
December 2024
INSERM Unit 1018, Team 5, CESP, Hôpital Paul Brousse, Paris-Sud University and Versailles Saint-Quentin-en-Yvelines University, Villejuif, France.
Pre-emptive kidney transplantation (PKT) has long been considered the optimal treatment for patients with end-stage chronic kidney disease (CKD) seeking the most favourable long-term outcomes. However, the significant growth in transplant procedures over recent decades has led to a notable increase in wait-listed patients and a disproportionate demand for donor organs. This situation necessitates a re-evaluation of transplantation timing and the establishment of rational indications from both societal and clinical perspectives.
View Article and Find Full Text PDFRe-Evaluation and Retrospective Comparison of Serum Neutralization Induced by Three Different Types of Inactivated SARS-CoV-2 Vaccines.
Vaccines (Basel)
October 2024
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Background: During the COVID-19 pandemic, three different types of inactivated SARS-CoV-2 vaccines, namely BBIBP-CorV, WIBP-CorV and CoronaVac, were manufactured and used for vaccination in China. However, as far as we know, no comparison of their induced serum neutralization has been carried out so far, possibly due to the regional difference in vaccine distribution, the difficulty in undertaking a comprehensive evaluation, and the intention to avoid unnecessary bias in populations for a certain type of inactivated vaccine.
Methods: Since all three of these inactivated vaccines are no longer produced and used for vaccination, here, we retrospectively compared the serum neutralizing activities induced by these three different types of inactivated SARS-CoV-2 vaccines.
Unraveling the impact of abdominal arterial calcifications on kidney transplant waitlist mortality through ensemble machine learning.
Sci Rep
October 2024
Department of Transplant, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
The scarcity of organ donors relative to the number of patients with End Stage Kidney Disease (ESKD) has led to prolonged waiting times for kidney transplants, contributing to elevated cardiovascular mortality risk. Transplant professionals are tasked with the complex allocation of limited organs to a vulnerable patient group facing heightened morbidity and mortality risk. The need for continuous re-evaluation of waitlisted patients is evident due to the significant number who perish while awaiting transplantation.
View Article and Find Full Text PDFEx vivo MFG-E8 treatment improves the function of lungs procured from cardiac death donors in preclinical porcine model.
Heliyon
July 2024
Department of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
Article Synopsis
- Ex vivo lung perfusion (EVLP) is a technique that assesses and restores donor lungs, particularly beneficial for marginal lungs from donation after circulatory death (DCD).
- The study examined the impact of milk fat globule epidermal growth factor 8 (MFG-E8) on lung function during EVLP using a swine model, revealing that MFG-E8 enhanced blood oxygen levels and reduced inflammation markers compared to other preservation methods.
- The results indicate that using MFG-E8 during EVLP can improve lung graft performance, suggesting its potential for clinical application to expand the availability of DCD lungs for transplantation.
Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy.
Transfusion
August 2024
Vitalant Research Institute, Denver, Colorado, USA.
Background: Critical shortages in the national blood supply have led to a re-evaluation of previously overlooked donor sources for blood products. As a part of that effort, red blood cells collected from therapeutic phlebotomy of donors on testosterone replacement therapy (TRT) have been conditionally approved for transfusion. However, platelets from TRT donors are not currently approved for use due to limited data on effects of supraphysiologic testosterone on recipient safety and platelet function.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!